Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Tekni-Plex Acquires Tech-Seal | Contract Pharma

What are you searching for?

Sign in
Breaking News

Tekni-Plex Acquires Tech-Seal

Expands technologies for closure liner and seal manufacturing

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Tekni-Plex, Inc. has acquired the assets of Tech-Seal Products, Inc., a manufacturer of closure liners and innerseals for food, pharmaceutical, cosmetic, and industrial applications at its manufacturing facility in Triadelphia, WV. Tech-Seal will retain its name and run as a division of Tekni-Plex.
 
The combination of Tech-Seal and Tekni-Plex expands technical capabilities for new product offerings. The combined company’s primary product lines include conventional primary liners, foam based liners, heat induction liners and inner seals, conventional seals and pressure sensitive adhesive inner seals.
 
“We are very pleased to be adding Tech-Seal’s manufacturing capabilities and product offerings to our liner business,” said Paul Young, Tekni-Plex’s chief executive officer.  “We look forward to the strong combination of Tech-Seal and Tekni-Plex’s Tri-Seal brand to provide our customers with top quality, service and innovative product offerings to support their business needs.”
 
Paul Yousif, Tech-Seal’s president, said, “We couldn’t be happier to be joining Tekni-Plex. Our customers will benefit significantly from this combination.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics